Mankind Pharma share price
You have to be logged in to add this to Watchlist.Mankind Pharma is trading -0.46% lower at Rs 2,129.00 as compared to its last closing price. Mankind Pharma has been trading in the price range of 2,151.40 & 2,116.10. Mankind Pharma has given 7.89% in this year & -0.53% in the last 5 days.
Mankind Pharma has TTM P/E ratio 48.18 as compared to the sector P/E of 30.83.There are 13 analysts who have initiated coverage on Mankind Pharma. There are 3 analysts who have given it a strong buy rating & 5 analysts have given it a buy rating. 1 analysts have given the stock a sell rating.
The company posted a net profit of 471.24 Crores in its last quarter.
Listed peers of Mankind Pharma include Jio Financial Services (0.61%), Mankind Pharma (-0.46%), Indian Renewable Energy Development Agency (5.71%) etc.
Mankind Pharma has a 74.87% promoter holding & 25.13% public holding.The Mutual Fund holding in Mankind Pharma was at 2.14% in 30 Jun 2024. The MF holding has decreased from the last quarter. The FII holding in Mankind Pharma was at 11.58% in 30 Jun 2024. The FII holding has decreased from the last quarter.
Mankind Pharma share price range
|
| ||||
|
| ||||
Mankind Pharma share Key Metrics
| Market Cap ( ₹ Cr.) | 85,689.84 | ||||||||||||||||||
|
|
Technical Trends
Long TermConsiders price movement over the last 6 months
Short TermConsiders price movement over the last 1-2 weeks
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Mankind Pharma Corporate actions
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
| 31-Jul-24 | Quarterly Results |
| 15-May-24 | Audited Results & Others |
| 31-Jan-24 | Quarterly Results |
| 31-Oct-23 | Quarterly Results |
| 02-Aug-23 | Quarterly Results |
| 30-May-23 | Audited Results |
| Meeting Date | Announcement On | Purpose |
| 22-Sep-23 | 02-Aug-23 | AGM |
FAQs about Mankind Pharma share price
Mankind Pharma is trading at 2129.00 as on Fri Jul 19 2024 10:19:15. This is -0.46% lower as compared to its previous closing price of 2138.90.
The market capitalization of Mankind Pharma is 85295.22 Cr as on Fri Jul 19 2024 10:19:15.
The average broker rating on Mankind Pharma is Buy. The breakup of analyst rating is given below -
- 3 analysts have given a strong buy rating
- 5 analysts have given a buy rating
- 4 analysts have given a hold rating
- 1 analysts have given a sell rating
- 0 analysts have given a strong sell rating
The 52 wk high for Mankind Pharma is 2488.65 whereas the 52 wk low is 1680.50
Mankind Pharma can be analyzed on the following key metrics -
- TTM P/E: 48.18
- Sector P/E: 30.83
- Dividend Yield: 0.00%
- D/E ratio: 0.02
Mankind Pharma reported a net profit of 1912.90 Cr in 2024.
Mankind Pharma Quick Links
Mankind Pharma Dividend Mankind Pharma Bonus Mankind Pharma News Mankind Pharma AGM Mankind Pharma Rights Mankind Pharma Splits Mankind Pharma Board Meetings Mankind Pharma Key Metrics Mankind Pharma Shareholdings Mankind Pharma Profit Loss Mankind Pharma Balance Sheet Mankind Pharma Cashflow Mankind Pharma Q1 Results Mankind Pharma Q2 Results Mankind Pharma Q3 Results Mankind Pharma Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks